Paras Healthcare Share Price & Earnings Call Analysis
₹730.80-1.15% today
- Market cap
- ₹7,907 Cr
- P/E
- 180.66
- ROE
- 12.96%
- PEG
- 4.05
- Price to sales
- 4.92
- Debt to equity
- 3.53
- EBITDA margin
- 19.68%
- Net profit margin
- 2.73%
- Promoter holding
- 63.95%
- Sales (last year)
- ₹1,606 Cr
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Financials of Paras Healthcare
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Pros & Cons
Paras Healthcare
Key positives and risks surfaced from the company insights section.
Pros
- Company has low interest coverage ratio.
- Company has a low return on equity of -3.55% over last 3 years.
- Debtor days have increased from 65.4 to 79.4 days.
Raw Insights
- Company has low interest coverage ratio.
- Company has a low return on equity of -3.55% over last 3 years.
- Debtor days have increased from 65.4 to 79.4 days.
Financials of Paras Healthcare
Quarterly Results
Quarter-by-quarter operating performance
| Sales + |
| Expenses + |
| Operating Profit |
| OPM % |
| Other Income + |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit + |
| EPS in Rs |
Financials of Paras Healthcare
Profit & Loss
Annual income statement trend
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 918 | 1,129 | 1,294 | 1,606 |
| Expenses + | 846 | 994 | 1,155 | 1,290 |
| Operating Profit | 71 | 135 | 139 | 316 |
| OPM % | 8% | 12% | 11% | 20% |
| Other Income + | 18 | 22 | 20 | 23 |
| Interest | 51 | 69 | 94 | 119 |
| Depreciation | 65 | 81 | 116 | 144 |
| Profit before tax | -27 | 7 | -50 | 76 |
| Tax % | 58% | 331% | 16% | 42% |
| Net Profit + | -43 | -15 | -58 | 44 |
| EPS in Rs | -4.38 | -1.57 | -5.94 | 4.34 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Financials of Paras Healthcare
Balance Sheet
Capital structure and asset base
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 4 | 10 | 10 | 10 |
| Reserves | 26 | 329 | 271 | 385 |
| Borrowings + | 756 | 548 | 1,232 | 1,394 |
| Other Liabilities + | 507 | 592 | 298 | 282 |
| Total Liabilities | 1,293 | 1,478 | 1,810 | 2,071 |
| Fixed Assets + | 780 | 988 | 1,173 | 1,211 |
| CWIP | 78 | 29 | 38 | 29 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets + | 435 | 461 | 599 | 832 |
| Total Assets | 1,293 | 1,478 | 1,810 | 2,071 |
Financials of Paras Healthcare
Cash Flows
Operating, investing and financing cash movement
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 44 | 92 | 86 | 164 |
| Cash from Investing Activity + | -126 | -194 | -147 | -239 |
| Cash from Financing Activity + | 97 | 94 | 83 | 86 |
| Net Cash Flow | 15 | -8 | 22 | 10 |
| Free Cash Flow | -69 | -102 | -49 | -5 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 106% | 76% | 69% | 69% |
Financials of Paras Healthcare
Ratios
Working capital efficiency and return ratios
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 52 | 51 | 66 | 79 |
| Inventory Days | 27 | 34 | 28 | 27 |
| Days Payable | 191 | 169 | 206 | 177 |
| Cash Conversion Cycle | -112 | -84 | -112 | -70 |
| Working Capital Days | -184 | -67 | -87 | -56 |
| ROCE % | 9% | 4% | 12% |